Terms: = Brain cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4
57 results:
1. A preliminary study on the mechanism of VASH2 in childhood medulloblastoma.
Liu W; Fu Y; Wang M; Zhao J; Chen J; Wang Y; Qin H
Sci Rep; 2023 Oct; 13(1):17153. PubMed ID: 37821528
[TBL] [Abstract] [Full Text] [Related]
2. Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy.
Hua YC; Gao DZ; Wang KY; Ding XS; Xu WR; Li YB; Shi WW; Sun SB; Li XY
Thorac Cancer; 2023 Nov; 14(31):3133-3139. PubMed ID: 37718465
[TBL] [Abstract] [Full Text] [Related]
3. Executive summary of the 14th HHT international scientific conference.
Ola R; Hessels J; Hammill A; Friday C; Clancy M; Al-Samkari H; Meadows S; Iyer V; Akhurst R
Angiogenesis; 2023 Aug; 26(Suppl 1):27-37. PubMed ID: 37695357
[TBL] [Abstract] [Full Text] [Related]
4. Endoscopic Endonasal Approach to Intraconal Orbital Tumors: Outcomes and Lessons Learned.
Sindwani R; Sreenath SB; Recinos PF
Laryngoscope; 2024 Jan; 134(1):47-55. PubMed ID: 37249188
[TBL] [Abstract] [Full Text] [Related]
5. [Advances of glioma biomarkers].
Hao M; Liang Y; Guo R; Li X; Li Y; Wang L; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1445-1461. PubMed ID: 37154316
[TBL] [Abstract] [Full Text] [Related]
6. Cell Cycle-Related FAM64A Could be Activated by TGF-β Signaling to Promote Glioma Progression.
Fu M; Zhang J; Zhang L; Feng Y; Fang X; Zhang J; Wen W; Hua W; Mao Y
Cell Mol Neurobiol; 2023 Aug; 43(6):2975-2987. PubMed ID: 37081231
[TBL] [Abstract] [Full Text] [Related]
7. A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung cancer Cells While Avoiding Hybrid States.
Kim N; Hwang CY; Kim T; Kim H; Cho KH
Cancer Res; 2023 Mar; 83(6):956-970. PubMed ID: 36710400
[TBL] [Abstract] [Full Text] [Related]
8. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.
Feng F; Zhao Z; Cai X; Heng X; Ma X
Cancer Med; 2023 Mar; 12(5):5889-5907. PubMed ID: 36284444
[TBL] [Abstract] [Full Text] [Related]
9. Identification of nine mutant genes and establishment of three prediction models of organ tropism metastases of non-small cell lung cancer.
Chen S; Huang W; Liu Z; Jin M; Li J; Meng L; Li T; Diao Y; Gao H; Hong C; Zheng J; Li F; Zhang Y; Bi D; Teng L; Li X
Cancer Med; 2023 Feb; 12(3):3089-3100. PubMed ID: 36161776
[TBL] [Abstract] [Full Text] [Related]
10. Differences in actionable genomic alterations between brain metastases and non‑brain metastases in patients with non‑small cell lung cancer.
Nian R; Jiang H; Zhao J; Hou W; Zhang H; Ma J; Lv P; Jiang L; Wang Y; Xu Y; Wu S; Lou J; Li W
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35796015
[TBL] [Abstract] [Full Text] [Related]
11. Valproic Acid Inhibits Glioma and Its Mechanisms.
Yang ZY; Wang XH
J Healthc Eng; 2022; 2022():4985781. PubMed ID: 35251569
[TBL] [Abstract] [Full Text] [Related]
12. Downregulation of CRX, a Group 3-specific oncogenic transcription factor, inhibits TGF-β/activin signaling in medulloblastoma cells.
Masurkar SA; Deogharkar A; Bharambe HS; Shirsat NV
Biochem Biophys Res Commun; 2021 Sep; 568():76-82. PubMed ID: 34192607
[TBL] [Abstract] [Full Text] [Related]
13. IDH1 gene mutation activates Smad signaling molecules to regulate the expression levels of cell cycle and biological rhythm genes in human glioma U87‑MG cells.
Gao Y; Wu Y; Zhang N; Yuan H; Wang F; Xu H; Yu J; Ma J; Hou S; Cao X
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760141
[TBL] [Abstract] [Full Text] [Related]
14. Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer.
Lee HS; Kim E; Lee J; Park SJ; Hwang HK; Park CH; Jo SY; Kang CM; Hong SM; Kang H; Jo JH; Cho IR; Chung MJ; Park JY; Park SW; Song SY; Han JM; Kim S; Bang S
EBioMedicine; 2021 Mar; 65():103218. PubMed ID: 33639403
[TBL] [Abstract] [Full Text] [Related]
15. Epithelial-mesenchymal transition polarization in ovarian carcinomas from patients with high social isolation.
Lutgendorf SK; Penedo F; Goodheart MJ; Dahmoush L; Arevalo JMG; Thaker PH; Slavich GM; Sood AK; Cole SW
Cancer; 2020 Oct; 126(19):4407-4413. PubMed ID: 32691853
[TBL] [Abstract] [Full Text] [Related]
16. Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma.
Georgescu MM; Islam MZ; Li Y; Circu ML; Traylor J; Notarianni CM; Kline CN; Burns DK
Acta Neuropathol Commun; 2020 Jul; 8(1):111. PubMed ID: 32680567
[TBL] [Abstract] [Full Text] [Related]
17. Growth-Inhibitory Activity of Bone Morphogenetic Protein 4 in Human Glioblastoma Cell Lines Is Heterogeneous and Dependent on Reduced SOX2 Expression.
Dalmo E; Johansson P; Niklasson M; Gustavsson I; Nelander S; Westermark B
Mol Cancer Res; 2020 Jul; 18(7):981-991. PubMed ID: 32234828
[TBL] [Abstract] [Full Text] [Related]
18. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract] [Full Text] [Related]
19. Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment.
Pepe F; Pisapia P; Del Basso de Caro ML; Conticelli F; Malapelle U; Troncone G; Martinez JC
Histol Histopathol; 2020 Jul; 35(7):741-749. PubMed ID: 31872418
[TBL] [Abstract] [Full Text] [Related]
20. A p53/TIAF1/WWOX triad exerts cancer suppression but may cause brain protein aggregation due to p53/WWOX functional antagonism.
Chou PY; Lin SR; Lee MH; Schultz L; Sze CI; Chang NS
Cell Commun Signal; 2019 Jul; 17(1):76. PubMed ID: 31315632
[TBL] [Abstract] [Full Text] [Related]
[Next]
